Covid-19: Covaxin trial starts today; Russia denies UK's hacking claims

Covaxin is an indigenously developed Covid-19 vaccine candidate, developed by a Hyderabad-based Bharat Biotech in collaboration with ICMR and NIV

Kanishka Gupta New Delhi

Listen to This Article

1 min read Last Updated : Jul 20 2020 | 2:07 PM IST

Connect with us

Living with a pandemic could be more difficult especially when we are not updated with the latest developments.

In this edition of Business Standard podcast, we will cover major coronavirus-related developments of the past 24 hours.

Click podcast for more

More From This Section

Maharashtra Congress minister Aslam Shaikh tests Covid-19 positive

Record single-day spike of 40,425 Covid cases; tally crosses 1.1 million

Kumaraswamy protests boards marking out houses of Covid-19 patients

Carrie Lam says Covid situation 'very severe', new measures in Hong Kong

Topics :Coronavirus Coronavirus Vaccine Coronavirus Tests Health Ministry Russian hackers

First Published: Jul 20 2020 | 1:12 PM IST